77 related articles for article (PubMed ID: 25667464)
41. Enhanced anticancer efficacy of snake venom combined with silica nanoparticles in a murine model of human multiple myeloma: molecular targets for cell cycle arrest and apoptosis induction.
Al-Sadoon MK; Rabah DM; Badr G
Cell Immunol; 2013; 284(1-2):129-38. PubMed ID: 23973876
[TBL] [Abstract][Full Text] [Related]
42. Characterization of multiple myeloma clonal cell expansion and stromal Wnt/β-catenin signaling in hyaluronic acid-based 3D hydrogel.
Narayanan NK; Duan B; Butcher JT; Mazumder A; Narayanan BA
In Vivo; 2014; 28(1):67-73. PubMed ID: 24425838
[TBL] [Abstract][Full Text] [Related]
43. Wnts induce migration and invasion of myeloma plasma cells.
Qiang YW; Walsh K; Yao L; Kedei N; Blumberg PM; Rubin JS; Shaughnessy J; Rudikoff S
Blood; 2005 Sep; 106(5):1786-93. PubMed ID: 15886323
[TBL] [Abstract][Full Text] [Related]
44. Utilizing ethacrynic acid and ciclopirox olamine in liver cancer.
Al-Dali AM; Weiher H; Schmidt-Wolf IGH
Oncol Lett; 2018 Nov; 16(5):6854-6860. PubMed ID: 30405829
[TBL] [Abstract][Full Text] [Related]
45. [Wnt signal inhibitors against multiple myeloma].
Nihon Rinsho; 2016 Jul; 74 Suppl 5():173-9. PubMed ID: 30615341
[No Abstract] [Full Text] [Related]
46. Doubling Down on Wnt Signaling to Overcome Myeloma Bone Disease.
Delgado-Calle J; Roodman GD
J Bone Miner Res; 2023 Jun; 38(6):812-813. PubMed ID: 37277117
[No Abstract] [Full Text] [Related]
47. Primary central nervous system lymphoma presenting with multiple myeloma-like clinical picture.
Celik I; Basçil N; Barista I; Güllü I; Tekuzman G; Firat D
J Neurol Neurosurg Psychiatry; 1997 Sep; 63(3):409-10. PubMed ID: 9328268
[No Abstract] [Full Text] [Related]
48. Neuropathy with malignant tumor metastases.
BARRON KD; ROWLAND LP; ZIMMERMAN HM
J Nerv Ment Dis; 1960 Jul; 131():10-31. PubMed ID: 13687318
[No Abstract] [Full Text] [Related]
49. Introduction to "Immunotherapies for Multiple Myeloma".
Offidani M; Petrucci MT
Pharmaceuticals (Basel); 2020 Nov; 13(11):. PubMed ID: 33212754
[TBL] [Abstract][Full Text] [Related]
50. Wnt signaling: bone's defense against myeloma.
Edwards CM
Blood; 2008 Jul; 112(2):216-7. PubMed ID: 18606884
[No Abstract] [Full Text] [Related]
51. Cinnarizine in the treatment of peripheral vascular disease: mechanisms related to its clinical action.
Emanuel MB; Will JA
Proc R Soc Med; 1977; 70(Suppl 8):7-12. PubMed ID: 20919380
[No Abstract] [Full Text] [Related]
52. Targeted Therapy in Leukaemia, Lymphoma and Myeloma.
Opat SS
J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055389
[TBL] [Abstract][Full Text] [Related]
53. Lıngual Dystonıa Related to the use of Cınnarızıne.
Eruyar E; İrkeç C
Ann Indian Acad Neurol; 2023; 26(3):288-289. PubMed ID: 37538431
[No Abstract] [Full Text] [Related]
54. Correction: Integration of Novel Agents into the Care of Patients with Multiple Myeloma.
Clin Cancer Res; 2017 May; 23(10):2605. PubMed ID: 28507271
[No Abstract] [Full Text] [Related]
55. Flunarizine exhibits in vitro efficacy against lymphoma and multiple myeloma cells.
Schmeel LC; Schmeel FC; Kim Y; Blaum-Feder S; Endo T; Schmidt-Wolf IG
Anticancer Res; 2015 Mar; 35(3):1369-76. PubMed ID: 25750287
[TBL] [Abstract][Full Text] [Related]
56. Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation.
Roy V; Stewart AK; Bergsagel PL; Dispenzieri A; Laumann K; Allred J; Lacy MQ; Fonseca R; Reeder CB; Kumar S; Rivera CE; Gertz MA; Buadi FK; Hayman SR; Rajkumar SV
Blood Cancer J; 2015 Mar; 5(3):e294. PubMed ID: 25794130
[No Abstract] [Full Text] [Related]
57. Novel Mucoadhesive Chitosomes as a Platform for Enhanced Oral Bioavailability of Cinnarizine.
Oransa HA; Boughdady MF; El-Sabbagh HM
Int J Nanomedicine; 2022; 17():5641-5660. PubMed ID: 36452306
[TBL] [Abstract][Full Text] [Related]
58. Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia.
Shi L; Huang R; Lai Y
BMC Med Genomics; 2021 May; 14(1):127. PubMed ID: 33985510
[TBL] [Abstract][Full Text] [Related]
59. Novel mTORC1 Inhibitors Kill Glioblastoma Stem Cells.
Sandoval JA; Tomilov A; Datta S; Allen S; O'Donnell R; Sears T; Woolard K; Kovalskyy D; Angelastro JM; Cortopassi G
Pharmaceuticals (Basel); 2020 Nov; 13(12):. PubMed ID: 33255358
[TBL] [Abstract][Full Text] [Related]
60. Identification of novel chemotherapeutic strategies for metastatic uveal melanoma.
Fagone P; Caltabiano R; Russo A; Lupo G; Anfuso CD; Basile MS; Longo A; Nicoletti F; De Pasquale R; Libra M; Reibaldi M
Sci Rep; 2017 Mar; 7():44564. PubMed ID: 28303962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
